Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

Non-alcoholic steatohepatitis (NASH) develops from non-alcoholic fatty liver disease (NAFLD). Currently, around 25% of the population is estimated to have NAFLD, and 25% of NAFLD patients are estimated to have NASH. NASH is typically characterized by liver steatosis inflammation, and fibrosis driven...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Cheng, Stewart, Alastair G., Woodman, Owen L., Ritchie, Rebecca H., Qin, Cheng Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745178/
https://www.ncbi.nlm.nih.gov/pubmed/33343375
http://dx.doi.org/10.3389/fphar.2020.603926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745178/
https://www.ncbi.nlm.nih.gov/pubmed/33343375
http://dx.doi.org/10.3389/fphar.2020.603926

Ejemplares similares